4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

Details 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs

2005-09-14

2010-10-12

Keys, Rosalynd (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S571000, C562S426000

Reexamination Certificate

active

07812053

ABSTRACT:
The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR modulators to treat or inhibit the progression of, for example, dyslipidemia.

REFERENCES:
patent: 4125732 (1978-11-01), McEvoy et al.
patent: 7425649 (2008-09-01), Kuo et al.
patent: 2005/0107469 (2005-05-01), Kuo et al.
patent: 2005/0124698 (2005-06-01), Kuo et al.
patent: 2006/0004091 (2006-01-01), Ackermann et al.
patent: 2006/0058382 (2006-03-01), Kuo et al.
patent: 2006/0257987 (2006-11-01), Valcarcel et al.
patent: 2007/0060649 (2007-03-01), Abdel-Magid et al.
patent: 2008/0269336 (2008-10-01), Kuo et al.
patent: 10195057 (1998-07-01), None
patent: WO 97/28115 (1997-08-01), None
patent: WO 02/062774 (2002-08-01), None
patent: WO 02/100813 (2002-12-01), None
Oliver, B. et al., “Differential Expression of Peroxisome Proliferator-Activated Receptors (PPARs): Tissue Distribution of PPAR-α, -β, and -y in the Adult Rat.”Endocrinology, 1996, 354-366, 137, No. 1.
Boden, G. “Free Fatty Acids, Insulin Resistance, and Type 2 Diabetes Mellitus.”PAAP, 1999, 241-248, vol. 111, No. 3.
Leibowitz, M. D. et al., “Activation of PPARσ alters lipid metabolism in db/db mice.”FEBS, 2000, 333-336, vol. 473.
PCT International Search Report, dated Jun. 3, 2006 for PCT Appln. No. PCT/US/2005/033137 which relates to U.S. Appl. No. 11/226,179, filed Sep. 14, 2005.
Auboeuf et al., “Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator-Activiated Receptors and Liver X Receptor-α in Humans.”, Diabetes, 1997, vol. 46, pp. 1319-1327.
Berge et al., “Pharmaceutical Salts.”, J. Pharm.Sci., 1977, vol. 66(1), pp. 1-19.
Lawn et al., “The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.”, J. Clin. Investigation, 1999, vol. 104(8), pp. R25-R31.
Oliver et al., “A selective Peroxisome proliferator-activated receptor σ agonist promotes reverse cholesterol transport.”, PNAS, 2001, vol. 98(9), pp. 5306-5311, USA.
Shi et al., “The peroxisome proliferator-activated receptor,an integrator of transcriptional repression and nuclear receptor signaling.”, Proc Natl. Acad. Sci., 2002, vol. 99(5), pp. 2613-2618, USA.

Affiliated with

Also associated with

Rating

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4202716